全文获取类型
收费全文 | 9249篇 |
免费 | 732篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 114篇 |
儿科学 | 315篇 |
妇产科学 | 212篇 |
基础医学 | 1192篇 |
口腔科学 | 43篇 |
临床医学 | 1236篇 |
内科学 | 1421篇 |
皮肤病学 | 222篇 |
神经病学 | 1147篇 |
特种医学 | 200篇 |
外科学 | 897篇 |
综合类 | 122篇 |
一般理论 | 5篇 |
预防医学 | 1347篇 |
眼科学 | 137篇 |
药学 | 628篇 |
中国医学 | 10篇 |
肿瘤学 | 752篇 |
出版年
2024年 | 25篇 |
2023年 | 132篇 |
2022年 | 202篇 |
2021年 | 485篇 |
2020年 | 241篇 |
2019年 | 385篇 |
2018年 | 468篇 |
2017年 | 341篇 |
2016年 | 347篇 |
2015年 | 373篇 |
2014年 | 460篇 |
2013年 | 608篇 |
2012年 | 938篇 |
2011年 | 953篇 |
2010年 | 453篇 |
2009年 | 383篇 |
2008年 | 604篇 |
2007年 | 549篇 |
2006年 | 484篇 |
2005年 | 465篇 |
2004年 | 354篇 |
2003年 | 280篇 |
2002年 | 248篇 |
2001年 | 43篇 |
2000年 | 13篇 |
1999年 | 25篇 |
1998年 | 32篇 |
1997年 | 15篇 |
1996年 | 12篇 |
1995年 | 12篇 |
1994年 | 8篇 |
1993年 | 6篇 |
1992年 | 5篇 |
1991年 | 10篇 |
1990年 | 4篇 |
1989年 | 4篇 |
1988年 | 2篇 |
1987年 | 3篇 |
1986年 | 9篇 |
1985年 | 2篇 |
1984年 | 3篇 |
1981年 | 2篇 |
1979年 | 1篇 |
1976年 | 3篇 |
1971年 | 1篇 |
1970年 | 1篇 |
1968年 | 2篇 |
1967年 | 1篇 |
1956年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
Abraham C. Thomas Erin N. Potts Ben T. Chen Deborah M. Slipetz W. Michael Foster Bastiaan Driehuys 《NMR in biomedicine》2009,22(5):502-515
Hyperpolarized (HP) 3He magnetic resonance imaging has been recently used to produce high‐resolution images of pulmonary ventilation after methacholine (MCh) challenge in mouse models of allergic inflammation. This capability presents an opportunity to gain new insights about these models and to more sensitively evaluate new drug treatments in the pre‐clinical setting. In the current study, we present our initial experience using two‐dimensional (2D), time‐resolved 3He MRI of MCh challenge‐induced airways hyperreactivity (AHR) to compare ovalbumin‐sensitized and challenged (N = 8) mice to controls (N = 8). Imaging demonstrated that ovalbumin‐sensitized and challenged animals exhibited many large ventilation defects even prior to MCh challenge (four out of eight) compared to no defects in the control animals. Additionally, the ovalbumin‐sensitized and challenged animals experienced a greater number of ventilation defects (4.5 ± 0.4) following MCh infusion than did controls (3.3 ± 0.6). However, due to variability in MCh delivery that was specific to the small animal MRI environment, the difference in mean defect number was not statistically significant. These findings are reviewed in detail and a comprehensive solution to the variability problem is presented that has greatly enhanced the magnitude and reproducibility of the MCh response. This has permitted us to develop a new imaging protocol consisting of a baseline 3D image, a time‐resolved 2D series during MCh challenge, and a post‐MCh 3D image that reveals persistent ventilation defects. Copyright © 2009 John Wiley & Sons, Ltd. 相似文献
83.
Kim IM Tilley DG Chen J Salazar NC Whalen EJ Violin JD Rockman HA 《Proceedings of the National Academy of Sciences of the United States of America》2008,105(38):14555-14560
Recent evidence suggests that binding of agonist to its cognate receptor initiates not only classical G protein-mediated signaling, but also beta-arrestin-dependent signaling. One such beta-arrestin-mediated pathway uses the beta(1)-adrenergic receptor (beta(1)AR) to transactivate the EGFR. To determine whether beta-adrenergic ligands that do not activate G protein signaling (i.e., beta-blockers) can stabilize the beta(1)AR in a signaling conformation, we screened 20 beta-blockers for their ability to stimulate beta-arrestin-mediated EGFR transactivation. Here we show that only alprenolol (Alp) and carvedilol (Car) induce beta(1)AR-mediated transactivation of the EGFR and downstream ERK activation. By using mutants of the beta(1)AR lacking G protein-coupled receptor kinase phosphorylation sites and siRNA directed against beta-arrestin, we show that Alp- and Car-stimulated EGFR transactivation requires beta(1)AR phosphorylation at consensus G protein-coupled receptor kinase sites and beta-arrestin recruitment to the ligand-occupied receptor. Moreover, pharmacological inhibition of Src and EGFR blocked Alp- and Car-stimulated EGFR transactivation. Our findings demonstrate that Alp and Car are ligands that not only act as classical receptor antagonists, but can also stimulate signaling pathways in a G protein-independent, beta-arrestin-dependent fashion. 相似文献
84.
85.
86.
87.
88.
Infections with hepatitis C virus (HCV) represent a substantial national and international public health burden. HCV has been associated with numerous extrahepatic conditions and can lead to metabolic derangements that are associated with atherosclerosis and cardiovascular disease. We investigated whether HCV infection is associated with an increased number of acute coronary syndrome (ACS) events among hospitalized patients in an inner-city tertiary hospital.We performed a matched (age, sex, and race/ethnicity) case-control study on patients at least 18 years old admitted to inpatient medical and cardiac services at the University of Maryland Medical Center from 2015 through 2018. The primary outcome was ACS and the primary exposure was HCV infection. Covariates of interest included: alcohol use, tobacco use, illicit drug use, hypertension, diabetes mellitus, human immunodeficiency virus infection, body mass index, dyslipidemia, and family history of coronary heart disease. Covariates with significant associations with both exposure and outcome in bivariate analyses were included in the multivariable analyses of the final adjusted model.There were 1555 cases and 3110 controls included in the final sample. Almost 2% of cases and 2.4% of controls were HCV infected. In adjusted models, there was no significant association found between experiencing an ACS event in those with HCV infection compared to those without HCV infection (odds ratio 0.71, 95% confidence interval 0.45–1.11).We found no significant association between HCV infection and ACS in our study population. However, given the mixed existing literature, the association between HCV and ACS warrants further investigation in future prospective cohort and/or interventional studies. 相似文献
89.
Development and evaluation of a treatment fidelity instrument for family‐based treatment of adolescent anorexia nervosa 下载免费PDF全文
90.